Skip to content
Menu
IGC Form 8-K Favorable Preliminary Clinical Trial Results
December 2, 2021
ALL
2023
2022
2021
2020
2019
2018
2017
Sec.gov
Menu
ALL
2023
2022
2021
2020
2019
2018
2017
Sec.gov
IGC-8-K-PR-Phase-1-Clinical-Trial-Data-Indicate-IGCs-THC-based-Investigational-New-Drug-May-Reduce-Symptoms-of-Dementia-in-Alzheimers-Patients-
Download
DOWLOAD XBRL FILES
LEADERSHIP
INVESTORS
PRESENTATIONS
PRESS RELEASES
SEC FILINGS
GOVERNANCE
CONTACT
Search